LOX and breast cancer: TGF-β and TNF-α, pro-inflammatory cytokines that are extensively expressed in the tumor microenvironment [53], upregulate the LOX expression via the reactive oxygen species–activated NF-κB/extracellular signal-related kinase pathway, thus promoting the progression of breast cancer metastasis [54].